Insiders Esperion Therapeutics, Inc.

Equities

ESPR

US29664W1053

Market Closed - Nasdaq Other stock markets 01:30:00 14/05/2024 am IST			5-day change	1st Jan Change
2.23 ^USD	+1.83%		+5.19%	-25.42%

07/05	Investor Sentiment Muted After Rate Cut Optimism, Stifling US Equity Futures Pre-Bell	MT
07/05	Top Premarket Gainers	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Esperion Therapeutics, Inc. Announces Board Changes	16/23/16	CI
Esperion Therapeutics Promotes Ben Halladay to Chief Financial Officer	17/22/17	MT
Esperion Therapeutics, Inc. Appoints Ben Halladay as Chief Financial Officer	17/22/17	CI
Esperion Announces Establishment of Scientific Advisory Board to Support Pipeline and Life Cycle Management	26/22/26	CI
Esperion Appoints J. Martin Carroll to Its Board of Directors	02/22/02	CI
Esperion Therapeutics, Inc. Announces Board Changes	29/22/29	CI
Richard B. Bartram to Step Down as Principal Accounting Officer of Esperion Therapeutics, Inc., Effective as of April 8, 2022	16/22/16	CI
Esperion Therapeutics, Inc. Announces Appointment of Eric Warren, R.Ph. as Chief Commercial Officer	02/22/02	CI
Esperion Appoints Benjamin O. Looker as General Counsel	04/22/04	CI
Landos Biopharma Appoints Tim Mayleben Interim Chief Executive	08/21/08	MT
Esperion Therapeutics, Inc Elect Seth H.Z. Fischer as Class III Director as the Chairperson of the Nominating and Governance Committee and Member of the Compliance Committee	02/21/02	CI
Esperion Appoints Seth H.Z. Fischer as Class III Director	01/21/01	CI
Esperion Therapeutics, Inc. Announces Management Changes	03/21/03	CI
ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer	28/21/28	CI
Insider Trends: Esperion Therapeutics Insider 90-Day Buying Trend Prolonged with Purchase	26/21/26	MT
Insider Trends: Insider Buying Continued with Purchase of Esperion Therapeutics Stock	21/21/21	MT
Esperion Therapeutics, Inc. Announces Management Changes	17/21/17	CI
Esperion Therapeutics, Inc. Appoints Sheldon Koenig as President and CEO	17/21/17	CI
Insider Trends: Esperion Therapeutics Insider Buy Scaling Back 90-Days of Sells	08/21/08	MT
Esperion Therapeutics, Inc. Announces Management Changes	15/20/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Esperion Therapeutics, Inc.

Equities

ESPR

US29664W1053

Insiders

Filters